Earnings
IBRX
16.74
+4.56%
0.73
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
111.00K
111.00K
--
--
27.25M
56.08M
--
--
--
91.74M
--
-91.63M
1.18M
--
-1.94M
--
-92.38M
5000.00
-92.38M
--
-92.38M
-92.38M
--
--
-0.89
FY 2019-12-31
43.00K
43.00K
--
--
18.96M
48.28M
--
--
--
67.85M
--
-67.81M
1.62M
--
301.00K
--
-65.89M
-97.00K
-65.79M
--
-65.79M
-65.79M
0.00
--
-0.70
FY 2018-12-31
47.00K
47.00K
--
--
42.92M
53.22M
--
--
--
98.44M
--
-98.39M
1.89M
--
-227.00K
--
-96.73M
-503.00K
-96.23M
--
-96.23M
-96.23M
0.00
--
-1.22
FY 2017-12-31
45.00K
45.00K
--
--
57.12M
39.74M
--
--
--
99.17M
--
-99.12M
3.64M
--
-1.44M
--
-96.92M
-52.19M
-44.72M
--
-44.72M
-44.72M
-51.70M
--
-0.56
FY 2016-12-31
44.00K
44.00K
--
--
95.39M
29.15M
--
--
--
124.54M
--
-124.50M
5.21M
--
-2.09M
--
-121.38M
-572.00K
-120.81M
--
-120.81M
-120.81M
--
--
-1.47

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out IBRX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze ImmunityBio Inc recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.